Syra Health To Discuss First Quarter 2025 Financial Results
Syra Health (OTCQB: SYRA), a healthcare technology company, has scheduled its first quarter 2025 financial results announcement for Thursday, May 8, 2025, before market open. The company will host a conference call at 9:00 a.m. ET on the same day to discuss the results. Investors can access the conference call via webcast through the company's investor relations website and submit questions via email. A replay of the webcast will be available in the investors section of Syra Health's website.
Syra Health (OTCQB: SYRA), un'azienda tecnologica nel settore sanitario, ha programmato l'annuncio dei risultati finanziari del primo trimestre 2025 per giovedì 8 maggio 2025, prima dell'apertura dei mercati. La società terrà una conference call alle 9:00 a.m. ET dello stesso giorno per discutere i risultati. Gli investitori potranno partecipare alla conference call tramite webcast sul sito web delle relazioni con gli investitori dell'azienda e inviare domande via email. Una registrazione del webcast sarà disponibile nella sezione investitori del sito di Syra Health.
Syra Health (OTCQB: SYRA), una empresa de tecnología sanitaria, ha programado el anuncio de sus resultados financieros del primer trimestre de 2025 para el jueves 8 de mayo de 2025, antes de la apertura del mercado. La compañía organizará una llamada conferencia a las 9:00 a.m. ET del mismo día para discutir los resultados. Los inversores podrán acceder a la llamada conferencia vía webcast a través del sitio web de relaciones con inversores de la empresa y enviar preguntas por correo electrónico. Una repetición del webcast estará disponible en la sección de inversores del sitio web de Syra Health.
Syra Health(OTCQB: SYRA)는 헬스케어 기술 회사로서 2025년 1분기 재무 실적 발표를 2025년 5월 8일 목요일 시장 개장 전으로 예정했습니다. 회사는 같은 날 오전 9시(동부시간)에 실적을 논의하기 위한 컨퍼런스 콜을 개최할 예정입니다. 투자자들은 회사 투자자 관계 웹사이트를 통해 웹캐스트로 컨퍼런스 콜에 접속할 수 있으며 이메일로 질문을 제출할 수 있습니다. 웹캐스트 녹화본은 Syra Health 웹사이트 투자자 섹션에서 이용 가능합니다.
Syra Health (OTCQB : SYRA), une entreprise de technologie de la santé, a programmé l'annonce de ses résultats financiers du premier trimestre 2025 pour le jeudi 8 mai 2025, avant l'ouverture des marchés. La société tiendra une conférence téléphonique à 9h00 ET le même jour pour discuter des résultats. Les investisseurs pourront accéder à la conférence téléphonique via un webcast sur le site des relations investisseurs de l'entreprise et poser des questions par email. Un replay du webcast sera disponible dans la section investisseurs du site de Syra Health.
Syra Health (OTCQB: SYRA), ein Unternehmen im Bereich Gesundheitstechnologie, hat die Bekanntgabe der Finanzergebnisse für das erste Quartal 2025 für Donnerstag, den 8. Mai 2025, vor Börsenöffnung, geplant. Das Unternehmen wird am selben Tag um 9:00 Uhr ET eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen. Investoren können über einen Webcast auf der Investor-Relations-Website des Unternehmens an der Telefonkonferenz teilnehmen und Fragen per E-Mail einreichen. Eine Aufzeichnung des Webcasts wird im Investor-Bereich der Syra Health-Website verfügbar sein.
- None.
- None.
Conference call will be held on Thursday, May 8, at 9:00 a.m. ET
Interested parties can access the conference call via webcast, available in the investors section of the company's website at https://ir.syrahealth.com/presentations/Q1-2025-earnings-call.
Investors who would like to submit a question to be addressed on the call should email corbin@haydenir.com.
A webcast replay will be available in the investors section of the company's website at https://ir.syrahealth.com/presentations/Q1-2025-earnings-call.
About Syra Health
Syra Health is a healthcare technology company powering better health in critical areas such as behavioral and mental health, population health, and the healthcare workforce. The company's leading-edge technology products and innovative services focus on prevention, access, and affordability. With a commitment to improving health, Syra Health is advancing healthcare solutions nationwide and around the world. For more information, please visit www.syrahealth.com.
Contacts
For Investor Inquiries:
Corbin Woodhull
Managing Director, Global Advisory
Hayden IR
602-476-1821
corbin@haydenir.com
For Media Inquiries:
Christine Drury
Director of Corporate Communications
Syra Health
463-345-5180
christined@syrahealth.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/syra-health-to-discuss-first-quarter-2025-financial-results-302443123.html
SOURCE Syra Health